Skip to main content
OMCL
NASDAQ Technology

Omnicell 10-Q Details Q3 GAAP Net Income of $11.0M and $155.9M Nine-Month Operating Cash Flow

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$39.41
Mkt Cap
$1.798B
52W Low
$31.75
52W High
$55
52W Position info
24% above low
Off High info
28% below high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

OMCL sits 24% above its 52-week low of $31.75.

Summary

Omnicell's Q3 10-Q backs up the October 29 release with $11.0 million of GAAP net income and $155.9 million of nine-month operating cash flow, though quarterly revenue fell 1% to $307.9 million.


Key Events · Earnings and Guidance · OMCL

  • Q3 GAAP Profit Nearly Doubles

    Net income was $11.0 million, or $0.24 per diluted share, versus $5.5 million ($0.12) in Q3 2025; nine-month net income reached $46.7 million ($1.01 diluted) against $4.1 million a year earlier.

  • Revenue Slips 1% in the Quarter

    Total revenue was $307.9 million versus $310.6 million, with product revenue down 3% to $173.1 million and service revenue up 1% to $134.8 million.

  • Cash Builds on Strong Operations

    Nine-month operating cash flow was $155.9 million versus $96.9 million, lifting cash and equivalents to $314.9 million from $196.5 million at December 31, 2025.

  • Margins Aided by Tariff Refund

    Q3 gross margin rose to 45% from 43% and nine-month margin to 46% from 43%, helped by a $14.5 million IEEPA tariff refund received in Q2 2026 and recorded mainly as a reduction to cost of product revenue.


Analysis · OMCL · Technology

The headline numbers were already out on October 29, but this 10-Q is where the quality of the quarter shows: GAAP net income of $11.0 million ($0.24 diluted) versus $5.5 million a year ago, and nine-month net income of $46.7 million against $4.1 million. Cash generation is the standout — $155.9 million from operations in nine months versus $96.9 million, lifting cash to $314.9 million from $196.5 million at year-end, with the $350 million revolver fully undrawn and covenants met. The caveats are that Q3 revenue actually slipped 1% to $307.9 million on weaker product sales, and part of the year-to-date margin gain came from a $14.5 million tariff refund booked in Q2 rather than operations. With the buyback program concluded and no repurchases in the quarter, capital return has stopped while the balance sheet builds.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, OMCL was trading at $39.41 on NASDAQ in the Technology sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $31.75 to $55.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

OMCL - Latest Insights

OMCL
Oct 29, 2026, 6:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.56
Real-time Price: $33.18 info
Change: -$3.38 (-9%) info
Market Cap: $1.526B info
OMCL
Oct 29, 2026, 6:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $36.56
Real-time Price: $33.18 info
Change: -$3.38 (-9%) info
Market Cap: $1.526B info
OMCL
Jul 30, 2026, 6:53 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $41.40
Real-time Price: $33.18 info
Change: -$8.22 (-20%) info
Market Cap: $1.526B info
OMCL
Jul 30, 2026, 6:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $41.40
Real-time Price: $33.18 info
Change: -$8.22 (-20%) info
Market Cap: $1.526B info
OMCL
Jul 30, 2026, 6:34 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $41.40
Real-time Price: $33.18 info
Change: -$8.22 (-20%) info
Market Cap: $1.526B info